Maynard Um
-
-
-
-
-
-
-
Piper Sandler Assumes Kymera Therapeutics (KYMR) at Overweight
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $134 at H.C. Wainwright
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $138 at BTIG
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Raised to $84 at H.C. Wainwright
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Kymera Therapeutics (KYMR)
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) Misses Q2 EPS by 12c
-
-
-
-
-
-
-
Kymera Therapeutics (KYMR) PT Lowered to $70 at Brookline Capital Markets
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

